Press Releases
20 Years ProBioGen: Invests €20 million in Mammalian Manufacturing Expansion
read more 20 Years ProBioGen: Invests €20 million in Mammalian Manufacturing Expansion
ProBioGen signs GlymaxX ADCC Enhancement Technology License Deal with Novartis
read more ProBioGen signs GlymaxX ADCC Enhancement Technology License Deal with Novartis
ProBioGen and Merus Sign Deal on GlymaxX® ADCC Enhancement Technology
read more ProBioGen and Merus Sign Deal on GlymaxX® ADCC Enhancement Technology
ProBioGen Upholds Strong Patent Position in Viral Vaccine Manufacturing Field
read more ProBioGen Upholds Strong Patent Position in Viral Vaccine Manufacturing Field